Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2008
12/02/2008US7459307 Composition for treatment of articular cartilage damage
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459299 Variant Humicola grisea CBH1.1
12/02/2008US7459298 Nucleic acid of given sequence; recombinant vectors; use in preparation of pharmaceutical kits
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459291 Chordin-like molecules and uses thereof
12/02/2008US7459270 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
12/02/2008US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection
12/02/2008US7459163 Infectious DNA as a vaccine against west nile and other flaviviruses
12/02/2008US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens
12/02/2008US7459152 Tissue graft comprises stem/progenitor cells, astrocytes, oligodendrocytes, and fibroblasts; kits for increasing the viability of cells; for treament of Parkinson's disease, Alzheimer's disease, Huntington's disease, epilepsy, and traumatic brain or spinal cord injury
12/02/2008CA2484533C Systems and method of embryo delivery for manufactured seeds
12/02/2008CA2475116C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
12/02/2008CA2385348C Promoter for regulating expression of foreign genes
12/02/2008CA2348377C Human orphan g protein-coupled receptors
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2256645C Recombinant .alpha.-2,3-sialyltransferases and their uses
12/02/2008CA2226400C Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
12/02/2008CA2212560C Expression of sucrose phosphorylase in plants
12/02/2008CA2205085C An in vitro system for determining formation of a.beta. amyloid
12/02/2008CA2152371C Dna amplification
12/02/2008CA2140538C Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
12/02/2008CA2100268C Method for culturing and transforming human stem cell-containing compositions
12/01/2008CA2590593A1 Mutated hoxb4 proteins with improved stability, and methods of use thereof
11/2008
11/30/2008CA2594214A1 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
11/27/2008WO2008144753A2 Antibodies to tnf alpha and use thereof
11/27/2008WO2008144580A2 Primate stem cells produced by somatic cell nuclear transfer
11/27/2008WO2008144518A1 Preparation of regulatory t cells using icam-1 co-stimulation
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144257A2 The sorghum aluminum tolerance gene, sbmate
11/27/2008WO2008143863A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
11/27/2008WO2008143835A1 Ghrelin protects substantia nigra dopamine neurons
11/27/2008WO2008143797A1 Methods of producing a secreted protein
11/27/2008WO2008143782A1 Preservation of bioactive materials by freeze dried foam
11/27/2008WO2008143769A1 Delivery of micro-and nanoparticles with blood platelets
11/27/2008WO2008143697A2 Antibody with protein a selectivity
11/27/2008WO2008143630A2 Recombinant hydrogen-producing cyanobacterium and uses thereof
11/27/2008WO2008143354A1 Pharmaceutical composition for enzyme replacement therapy
11/27/2008WO2008143255A1 Method for production of cell population
11/27/2008WO2008143150A1 Gene-disrupted strain, recombinant plasmid, transformant and method of producing 3-carboxymuconolactone
11/27/2008WO2008143149A1 Cell sheet having good dimensional stability, method for production thereof, and cell culture carrier for use in the method
11/27/2008WO2008143047A1 Method for production of dendritic cell
11/27/2008WO2008142129A2 Partially degradable scaffolds for biomedical applications
11/27/2008WO2008142124A1 Recombinant protein production in avian ebx® cells
11/27/2008WO2008141818A1 Nucleic acid molecules coding for a protein with deacetylase activity, said protein, and method for the production of chitosan
11/27/2008WO2008141651A1 Efficient cell culture system for hepatitis c virus genotype 5a
11/27/2008WO2008141511A1 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF
11/27/2008WO2008124169A3 Islet cells composition and methods
11/27/2008WO2008118410A3 Quantum dot labeled stem cells for use in providing pacemaker function
11/27/2008WO2008116713A3 Apocrine cell line
11/27/2008WO2008113017A3 Compositions, systems, and methods for preservation and/or stabilization of a cell and/or macromolecule
11/27/2008WO2008103966A3 Compositions and methods using toll-like receptors and unc93b
11/27/2008WO2008103462A3 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
11/27/2008WO2008101233A3 Mitochondrial nucleic acid delivery systems
11/27/2008WO2008097885A3 Decellularization of soft tissue
11/27/2008WO2008094512A3 System for expression of genes in plants from a virus-based expression vector
11/27/2008WO2008076980A3 Generation of plants with altered oil, protein, or fiber content
11/27/2008WO2008070765A3 Light-sensitive constructs for inducing cell death and cell signaling
11/27/2008WO2008069956A3 Assays to predict and monitor antibody mediated rejection of transplanted allografts
11/27/2008WO2008060374A3 Methods and compositions useful for diabetic wound healing
11/27/2008WO2008058273A3 Dedifferentiation of adult mammalian cardiomyocytes into cardiac stem cells
11/27/2008WO2008036916A3 Phytases, nucleic acids encoding them and methods for making and using them
11/27/2008WO2008033517A3 Cell culture improvements
11/27/2008WO2008033393A3 Isolation, expansion and uses of tumor stem cells
11/27/2008WO2008030612A3 Site specific incorporation of non-natural amino acids by vertebrate cells
11/27/2008WO2008024769A3 Intensified perfusion production method
11/27/2008WO2008010859A3 Plant superoxide dismutase expression resistant to micro-rna regulation
11/27/2008WO2008008333A3 Bioassays for quality control of nutriceuticals that inhibit, upregulate or otherwise modulate translation initiation
11/27/2008WO2008008160A3 High efficiency flp site-specific recombination in mammalian cells using an optimized flp gene
11/27/2008WO2008002480A3 Transgenic crop plants with improved stress tolerance
11/27/2008WO2007146105A3 Procurement, isolation and cryopreservation of fetal placental cells
11/27/2008WO2007143582A3 Reversal of the suppressive function of specific t cells via toll-like receptor 8 signaling
11/27/2008WO2007140340A3 Formation of vascular networks using embryonic stem cells
11/27/2008WO2007136518A3 Treatment of autoimmune disorders
11/27/2008WO2007134220A3 A general method for generating human antibody responses in vitro
11/27/2008WO2007121443A3 Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
11/27/2008WO2007101002A3 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling
11/27/2008WO2007100845A3 Non-embryonic totipotent blastomere-like stem cells and methods therefor
11/27/2008WO2007095055A3 Methods and compositions for detecting viral nucleic acid in a cell
11/27/2008WO2007089572A3 Proliferative primary human sertoli cell cultures and their applications
11/27/2008WO2006044612A3 Development of sensitive fret sensors and methods of using the same
11/27/2008US20080295204 Dgat genes from yarrowia lipolytica for increased seed storage lipid production and altered fatty acid profiles in soybean
11/27/2008US20080295202 Soybean promoters SC194 and flower-preferred expression thereof in transgenic plants
11/27/2008US20080295201 Soybean promoters LTP2 and flower-preferred expression thereof in transgenic plants
11/27/2008US20080295199 Modulation of Plant Growth By Altering Amino Acid Uptake
11/27/2008US20080295197 Stimulating root growth; point mutations
11/27/2008US20080295196 Genes and uses for plant improvement
11/27/2008US20080295190 comprising a Cricetulus griseus ( FAIM, FADD, PDCD6 and Requiem) sequence capable of mediating apoptosis of cells
11/27/2008US20080295186 Neurotrypsin overexpressing animal
11/27/2008US20080295185 Transgenic Mouse Models of Hepatitis C Virus (Hcv) and Identification of Hvc Therapeutics
11/27/2008US20080293921 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue
11/27/2008US20080293917 Peptide Purification By Means Of Metal Ion Affinity Chromatography
11/27/2008US20080293699 Inhibitors of thapsigargin-induced cell death
11/27/2008US20080293663 Cellular genes regulated by hiv-1 infection and methods of use thereof
11/27/2008US20080293654 Therapeutic methods using Smads
11/27/2008US20080293640 Polypeptide inhibitors of HSP27 kinase and uses therefor
11/27/2008US20080293634 C-met receptor regulation by angiotensin iv (at4) receptor ligands
11/27/2008US20080293629 Albumin Fusion Proteins
11/27/2008US20080293628 Methods and Compositions for the Inhibition of Thrombus Formation
1 ... 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 ... 1827